Alkali Metals Limited Schedules Board Meeting on May 26, 2026 to Approve Q4 and FY26 Audited Financial Results

1 min read     Updated on 19 May 2026, 01:00 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Alkali Metals Limited has intimated stock exchanges of a Board of Directors meeting scheduled for May 26, 2026, to be held via two-way audio-visual means under Regulation 29 of SEBI (LODR) Regulations, 2015. The board will consider and approve audited financial results for the fourth quarter and financial year ended March 31, 2026. Additionally, the board will deliberate on the recommendation of a dividend, if any, along with other business matters. The intimation was filed on May 18, 2026, by Company Secretary & Compliance Officer Siddharth Dubey.

powered bylight_fuzz_icon
40678211

*this image is generated using AI for illustrative purposes only.

Alkali Metals Limited has notified the stock exchanges of a forthcoming Board of Directors meeting, scheduled for Tuesday, May 26, 2026. The meeting will be conducted through two-way audio-visual means, in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was filed on May 18, 2026, and signed by Siddharth Dubey, Company Secretary & Compliance Officer.

Board Meeting Details

The following key agenda items have been disclosed for the upcoming board meeting:

Parameter: Details
Meeting Date: Tuesday, May 26, 2026
Mode: Two-way audio-visual means
Regulatory Basis: Regulation 29, SEBI (LODR) Regulations, 2015
Financial Period Under Review: Fourth Quarter and Financial Year ended March 31, 2026
Key Agenda Items: Approval of Audited Financial Results, Dividend recommendation (if any), Other business items

Agenda Overview

The primary purpose of the meeting is to consider and approve the audited financial results of the company for the fourth quarter and the full financial year ended on March 31, 2026. In addition to the financial results, the board will also deliberate on the recommendation of a dividend, if any, for the relevant period. Other business items are also listed on the agenda, though further details have not been disclosed in the intimation.

About Alkali Metals Limited

Alkali Metals Limited is headquartered at Plot B-5, Block III, IDA, Uppal, Hyderabad – 500 039, India. The company is engaged in the manufacture of a range of specialty chemicals and pharmaceutical intermediates, including:

  • Sodium Amide
  • Sodium Alkoxides
  • Sodium Hydride
  • Sodium Azide
  • Tetrazoles
  • Amino Pyridines
  • Pyridine Derivatives
  • Cyclic Compounds
  • Fine Chemicals
  • Intermediates for pharmaceuticals
  • Active Pharmaceutical Ingredients

The company holds ISO 9001 & 14001 certifications and operates under CIN: L27109TG1968PLC001196.

Historical Stock Returns for Alkali Metals

1 Day5 Days1 Month6 Months1 Year5 Years
-2.96%+29.53%+30.42%+4.38%-14.32%+44.68%

How might Alkali Metals Limited's FY2026 financial results compare to industry peers in the specialty chemicals and pharmaceutical intermediates sector?

What factors could influence the board's decision on dividend recommendation, given current market conditions and the company's capital expenditure plans?

Could the approval of FY2026 audited results trigger any strategic announcements, such as capacity expansions or new product launches in the pharmaceutical intermediates space?

Alkali Metals Limited Submits Quarterly Compliance Certificate for Q4 FY26

1 min read     Updated on 16 Apr 2026, 09:23 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Alkali Metals Limited submitted its quarterly confirmation certificate under SEBI Regulation 74(5) for Q4 FY26 to NSE and BSE on April 15, 2026. The certificate from registrar Cameo Corporate Services Limited confirms proper handling of dematerialization procedures and compliance with depository participant regulations during the quarter ended March 31, 2026.

powered bylight_fuzz_icon
37857237

*this image is generated using AI for illustrative purposes only.

Alkali metals Limited has submitted its quarterly confirmation certificate under SEBI regulations to stock exchanges, demonstrating continued compliance with regulatory requirements for the quarter ended March 31, 2026.

Regulatory Compliance Submission

The company filed its confirmation certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 with both the National Stock Exchange of India Limited and BSE Limited on April 15, 2026. Company Secretary and Compliance Officer Siddharth Dubey signed and submitted the documentation to ensure regulatory adherence.

Exchange Details: Information
NSE Symbol: ALKALI (EQ Series)
BSE Scrip Code: 533029
Submission Date: April 15, 2026
Quarter Ended: March 31, 2026

Registrar Confirmation

M/s. Cameo Corporate Services Limited, serving as the company's Registrar and Share Transfer Agents, issued the confirmation certificate on April 06, 2026. The certificate validates that all securities received from depository participants for dematerialization during the quarter were properly processed and confirmed to the depositories.

Compliance Verification

The registrar confirmed several key compliance aspects in their certificate:

  • Securities received for dematerialization were accepted or rejected appropriately
  • All securities comprised in certificates have been listed on stock exchanges where previously issued securities are traded
  • Security certificates received for dematerialization were mutilated and cancelled after proper verification
  • Depository names were substituted in the Register of Members as registered owners within the mandated 15-day period

Corporate Information

Alkali Metals Limited operates from Plot B-5, Block III, IDA, Uppal, Hyderabad, and specializes in manufacturing sodium-based chemicals, pharmaceutical intermediates, and active pharmaceutical ingredients. The company maintains ISO 9001 and 14001 certifications, reflecting its commitment to quality and environmental management standards.

Historical Stock Returns for Alkali Metals

1 Day5 Days1 Month6 Months1 Year5 Years
-2.96%+29.53%+30.42%+4.38%-14.32%+44.68%

How might Alkali Metals' consistent regulatory compliance position the company for potential institutional investor interest in upcoming quarters?

What impact could the growing pharmaceutical intermediates market have on Alkali Metals' revenue growth trajectory in FY 2026-27?

Will Alkali Metals consider expanding its sodium-based chemicals manufacturing capacity given the increasing demand in the specialty chemicals sector?

More News on Alkali Metals

1 Year Returns:-14.32%